Long regarded as cells involved primarily in allergic responses and antiparasitic defense, eosinophils are now drawing ...
Pretreatment eosinophilia in NSCLC patients is associated with increased immune-related adverse events and reduced progression-free survival when treated with ICIs. The review included 11 ...
Enfortumab vedotin (EV) in non-squamous and squamous non–small cell lung cancer (NSCLC) cohorts of EV-202. High-dose furmonertinib in patients with EGFR-mutated non-small cell lung cancer and ...
Some people with very severe asthma symptoms have a condition called eosinophilic asthma. People with this type of asthma may need to use inhaled medicines along with a newer type of medicine that is ...
Pregnant patients with a periconception eosinophil count of at least vs. less than 300 cells/L had more asthma exacerbations while pregnant, according to data presented at the American Thoracic ...
Many people with COPD can control their symptoms by using inhaled medicines each day. But inhaled medicines may not offer enough relief for people who also have high levels of a type of white blood ...
Connect Biopharma (NASDAQ:CNTB) Chief Executive Officer Barry Quart said the company's rademikibart program continues to show a differentiated clinical and mechanistic profile as the company awaits ...
(Reuters) -British drugmaker GSK said on Friday that its asthma drug, Nucala, met the main goal of a late-stage study in treating patients with chronic obstructive pulmonary disease (COPD), or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results